ANI Pharmaceuticals ANIP saw its IBD SmartSelect Composite Rating rise to 96 Thursday, up from 93 the day before. Please ...

PALI-2108 is the first and only PDE4 inhibitor in development designed for targeted delivery to the terminal ileum and colon, addressing significant unmet needs in ulcerative colitis (UC) and ...

A Relative Strength Rating upgrade for Huntington Bancshares shows improving technical performance. Will it continue?

Palisade Bio, Inc. (NASDAQ: PALI) shares barely cleared breakeven Wednesday. The company, a clinical-stage biopharmaceutical ...

32 Biosciences, a gastrointestinal (GI)-focused biotechnology company pioneering gut mucosal-immune science to prevent and treat GI diseases, today announced that it will officially launch its $40 ...

The data, released Monday, also included one late report of a pediatric death from last season, bringing the total to 289 ...

The size of the cut matters less than what was left behind and what it says about where diversification stops being worth the drag.

AbolerIS Pharma ("AbolerIS"), a clinical-stage biopharmaceutical company committed to improving the lives of people suffering from autoimmune and inflammatory diseases, announced today that the first ...

Spyre Therapeutics, Inc. (NASDAQ: SYRE) (the “Company” or “Spyre”), a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of care ...

CoStar Group plans to reduce its net investment in listings site Homes.com by at least $100 million every year until 2030.

Discord is not publicly traded as of late-2025, meaning you can't buy its stock using a brokerage account. The platform may opt for an IPO or direct listing when it goes public, but timing remains ...

U.S. stock indexes finished mixed Thursday as the added 0.55%. Meanwhile, the was flat, and the dropped 0.44%.